Suppr超能文献

印度尼西亚新冠病毒自然感染和疫苗接种所引发抗体的中和能力比较:一项前瞻性队列研究

Comparison between Neutralization Capacity of Antibodies Elicited by COVID-19 Natural Infection and Vaccination in Indonesia: A Prospective Cohort.

作者信息

Nurisyah Sitti, Iyori Mitsuhiro, Hasyim Ammar Abdurrahman, Sakamoto Akihiko, Hashimoto Hinata, Yamagata Kyouhei, Yamauchi Saya, Amru Khaeriah, Zainal Kartika Hardianti, Idris Irfan, Yoshida Shigeto, Djaharuddin Irawaty, Syafruddin Din, Bukhari Agussalim, Asih Puji Budi Setia, Yusuf Yenni

机构信息

Faculty of Medicine, Hasanuddin University, Makassar 90245, Indonesia.

Dr. Tadjuddin Chalid Hospital, Makassar 90241, Indonesia.

出版信息

Antibodies (Basel). 2023 Sep 21;12(3):60. doi: 10.3390/antib12030060.

Abstract

BACKGROUND

To fight the COVID-19 pandemic, immunity against SARS-CoV-2 should be achieved not only through natural infection but also by vaccination. The effect of COVID-19 vaccination on previously infected persons is debatable.

METHODS

A prospective cohort was undergone to collect sera from unvaccinated survivors and vaccinated persons-with and without COVID-19 pre-infection. The sera were analyzed for the anti-receptor binding domain (RBD) titers by ELISA and for the capacity to neutralize the pseudovirus of the Wuhan-Hu-1 strain by luciferase assays.

RESULTS

Neither the antibody titers nor the neutralization capacity was significantly different between the three groups. However, the correlation between the antibody titers and the percentage of viral neutralization derived from sera of unvaccinated survivors was higher than that from vaccinated persons with pre-infection and vaccinated naïve individuals (Spearman correlation coefficient () = -0.8558; 95% CI, -0.9259 to -0.7288), < 0.0001 vs. -0.7855; 95% CI, -0.8877 to -0.6096, < 0.0001 and -0.581; 95% CI, -0.7679 to -0.3028, = 0.0002, respectively), indicating the capacity to neutralize the virus is most superior by infection alone.

CONCLUSIONS

Vaccines induce anti-RBD titers as high as the natural infection with lower neutralization capacity, and it does not boost immunity in pre-infected persons.

摘要

背景

为抗击新冠疫情,不仅应通过自然感染,还应通过接种疫苗来实现对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的免疫。新冠疫苗接种对既往感染者的效果存在争议。

方法

进行一项前瞻性队列研究,收集未接种疫苗的康复者以及接种疫苗者(无论之前是否感染过新冠)的血清。通过酶联免疫吸附测定(ELISA)分析血清中的抗受体结合域(RBD)滴度,并通过荧光素酶测定评估其中和武汉-1株假病毒的能力。

结果

三组之间的抗体滴度和中和能力均无显著差异。然而,未接种疫苗的康复者血清中抗体滴度与病毒中和百分比之间的相关性高于既往感染过新冠的接种者和未感染过新冠的接种者(斯皮尔曼相关系数()=-0.8558;95%置信区间,-0.9259至-0.7288),分别与-0.7855;95%置信区间,-0.8877至-0.6096,<0.0001和-0.581;95%置信区间,-0.7679至-0.3028,=0.0002相比),表明仅通过感染中和病毒的能力最为优越。

结论

疫苗诱导的抗RBD滴度与自然感染一样高,但中和能力较低,并且对既往感染者不会增强免疫力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ac/10526084/24663b8db046/antibodies-12-00060-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验